Evelina Tacconelli (MD, PhD) is a Full Professor of Infectious Diseases at the University of Verona, Italy and Head of the DZIF Clinical Research Unit on healthcare associated infections and antimicrobial resistance at the Tübingen University, Germany. She has been Lecturer on Medicine at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA. She was recipient of award from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for research excellence. Consultant for WHO, ECDC and EMA on infection control and antimicrobial resistance. Main areas of her scientific interest are epidemiology, clinical and therapeutic aspects of healthcare-associated infections and preventive measures aimed to reduce the spreading of antibiotic-resistant bacteria. She is the ESCMID Guideline Officer for Infectious Diseases and Clinical Microbiology. Member of the SAB of the JPI-AMR. Chair of the European Committee of Infection Control (EUCIC). Chair of the ESCMID guidelines on prevention and therapy of infections due to multidrug-resistant Gram negative bacteria (MDR-GN) and EUCIC guideline on decolonization procedures for patients colonized with MDR-GN. Chair of the 2018 WHO Priority List of Pathogens for R&D of new antibiotics. Involved (partner site or coordinator) in many European studies on prevention and transmission of infections caused by antibiotic-resistant bacteria financed by European Commission, WHO, JPI-AMR, Horizon2020, DG-Sanco, IMI, and DZIF. She serves on the International Advisory Board of Lancet Infectious Diseases, Editorial Board of Journal of Antimicrobial Chemotherapy and Scientific Committee of Clinical Microbiology and Infection. Author and co-author of more than 200 papers listed in SCI-JCR and NIH Medline.

Professor Evelina Tacconelli, University of Verona, Italy and Tübingen University, Germany